Bayer Patent Invalidated Due To Obviousness
The federal court overseeing Bayer Schering Pharma AG's patent suit against Barr Laboratories Inc. over the $488 million U.S. market for the contraceptive Yasmin has declared the patent at issue invalid...To view the full article, register now.
Already a subscriber? Click here to view full article